{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Solution&page=28", "query": { "intervention": "Control Solution", "page": 28 }, "page_size": 10 }, "pagination": { "page": 28, "page_size": 10, "total_count": 3229, "total_pages": 323, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Solution&page=29&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Solution&page=27&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-24T22:15:44.200Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00755781", "title": "Study of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung Transplantation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Lung Transplant" ], "interventions": [ { "name": "Cyclosporine Inhalation Solution (CIS)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "APT Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 284, "start_date": "2008-09", "completion_date": "2011-11", "has_results": false, "last_update_posted_date": "2012-09-17", "last_synced_at": "2026-10-24T22:15:44.200Z", "location_count": 18, "location_summary": "Los Angeles, California • San Francisco, California • Stanford, California + 15 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00755781" }, { "nct_id": "NCT02453334", "title": "Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Study to Investigate the Efficacy and Safety of Injectafer®", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cancer and Chemotherapy Related Anemia" ], "interventions": [ { "name": "Injectafer", "type": "DRUG" }, { "name": "Normal Saline", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "American Regent, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 244, "start_date": "2015-05-23", "completion_date": "2018-01-04", "has_results": true, "last_update_posted_date": "2021-05-11", "last_synced_at": "2026-10-24T22:15:44.200Z", "location_count": 29, "location_summary": "Corona, California • Fountain Valley, California • Riverside, California + 23 more", "locations": [ { "city": "Corona", "state": "California" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Riverside", "state": "California" }, { "city": "Boynton Beach", "state": "Florida" }, { "city": "Miami Lakes", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02453334" }, { "nct_id": "NCT07395232", "title": "An Efficacy and Safety Study of DFL24498 in the Treatment of AKC", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atopic Keratoconjunctivitis" ], "interventions": [ { "name": "DFL24498", "type": "DRUG" }, { "name": "Vehicle", "type": "DRUG" }, { "name": "dexamethasone sodium phosphate (DSP) ophthalmic solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dompé Farmaceutici S.p.A", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "10 Years to 65 Years" }, "enrollment_count": 153, "start_date": "2025-12-01", "completion_date": "2027-05", "has_results": false, "last_update_posted_date": "2026-09-21", "last_synced_at": "2026-10-24T22:15:44.200Z", "location_count": 8, "location_summary": "Jacksonville, Florida • Miami, Florida • Morrow, Georgia + 5 more", "locations": [ { "city": "Jacksonville", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Morrow", "state": "Georgia" }, { "city": "St Louis", "state": "Missouri" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07395232" }, { "nct_id": "NCT02207621", "title": "Evaluation of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma and Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ocular Hypertension", "Open-angle Glaucoma" ], "interventions": [ { "name": "AR-13324 Ophthalmic Solution 0.02%", "type": "DRUG" }, { "name": "Timolol maleate Ophthalmic Solution 0.5% BID", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" }, { "name": "AR-13324 Ophthalmic Solution 0.02% BID", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Aerie Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "99 Years", "sex": "ALL", "summary": "Up to 99 Years" }, "enrollment_count": 756, "start_date": "2014-07", "completion_date": "2016-03", "has_results": true, "last_update_posted_date": "2018-04-06", "last_synced_at": "2026-10-24T22:15:44.200Z", "location_count": 1, "location_summary": "Bedminster, New Jersey", "locations": [ { "city": "Bedminster", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT02207621" }, { "nct_id": "NCT06709716", "title": "Impact of Preoperative Quadratus Lumborum Block on Postoperative Opioid Consumption After Laparoscopic Hysterectomy", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Postoperative Pain", "Laparoscopic Hysterectomy", "Nerve Block", "Quadratus Lumborum Block" ], "interventions": [ { "name": "Quadratus Lumborum Block (QLB)", "type": "DRUG" }, { "name": "Quadratus lumborum block", "type": "DRUG" }, { "name": "Local Anesthetic Solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Walter Reed National Military Medical Center", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 76, "start_date": "2024-12-01", "completion_date": "2026-02", "has_results": false, "last_update_posted_date": "2024-11-29", "last_synced_at": "2026-10-24T22:15:44.200Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT06709716" }, { "nct_id": "NCT04862221", "title": "TReatment for ImmUne Mediated PathopHysiology", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Liver Failure", "Fulminant Hepatic Failure", "Hepatic Encephalopathy", "Acute Liver Injury", "Immune Dysregulation" ], "interventions": [ { "name": "High-dose methylprednisolone", "type": "DRUG" }, { "name": "Equine anti-thymocyte globulin", "type": "DRUG" }, { "name": "Prednisolone", "type": "DRUG" }, { "name": "Placebo for prednisolone", "type": "DRUG" }, { "name": "Placebo for infusions", "type": "DRUG" }, { "name": "Diphenhydramine", "type": "DRUG" }, { "name": "Methylprednisolone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "18 Years", "sex": "ALL", "summary": "1 Year to 18 Years" }, "enrollment_count": 44, "start_date": "2022-02-09", "completion_date": "2027-02", "has_results": false, "last_update_posted_date": "2026-08-12", "last_synced_at": "2026-10-24T22:15:44.200Z", "location_count": 17, "location_summary": "Los Angeles, California • Palo Alto, California • San Diego, California + 14 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT04862221" }, { "nct_id": "NCT04413552", "title": "INDV-2000 First in Human", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Opioid Dependence" ], "interventions": [ { "name": "INDV-2000", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Indivior Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 73, "start_date": "2020-07-06", "completion_date": "2021-04-13", "has_results": true, "last_update_posted_date": "2024-05-16", "last_synced_at": "2026-10-24T22:15:44.200Z", "location_count": 1, "location_summary": "Overland Park, Kansas", "locations": [ { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04413552" }, { "nct_id": "NCT04155047", "title": "A Clinical Study to Investigate if a Single Dose of an Approved Drug Product (Glycopyrrolate Inhalation Solution) Reduces Trapped Air in the Lungs of Participants With Chronic Obstructive Pulmonary Disease.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Chronic Obstructive Pulmonary Disease (COPD)" ], "interventions": [ { "name": "Glyocopyrrolate Inhalation Solution administered by Magnair", "type": "COMBINATION_PRODUCT" }, { "name": "Placebo administered by Magnair", "type": "DRUG" } ], "intervention_types": [ "COMBINATION_PRODUCT", "DRUG" ], "sponsor": "Sunovion Respiratory Development Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "40 Years to 99 Years" }, "enrollment_count": 44, "start_date": "2019-11-07", "completion_date": "2020-03-31", "has_results": true, "last_update_posted_date": "2021-05-10", "last_synced_at": "2026-10-24T22:15:44.200Z", "location_count": 1, "location_summary": "Saint Charles, Missouri", "locations": [ { "city": "Saint Charles", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT04155047" }, { "nct_id": "NCT04801108", "title": "Combined Zephyr Valve System With Inter-lobar Fissure Completion for Lung Volume Reduction in Emphysema", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Emphysema or COPD" ], "interventions": [ { "name": "Robotic or VATS lobar fissure completion", "type": "PROCEDURE" }, { "name": "Endobronchial valves placement", "type": "DEVICE" } ], "intervention_types": [ "PROCEDURE", "DEVICE" ], "sponsor": "Beth Israel Deaconess Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "40 Years to 75 Years" }, "enrollment_count": 20, "start_date": "2021-08-01", "completion_date": "2026-08-01", "has_results": false, "last_update_posted_date": "2026-04-13", "last_synced_at": "2026-10-24T22:15:44.200Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04801108" }, { "nct_id": "NCT01428050", "title": "The Use of a Restrictive Fluid Regimen With Hypertonic Saline for Patients Undergoing Pancreaticoduodenectomy", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pancreaticoduodenectomy" ], "interventions": [ { "name": "3% NaCl Solution", "type": "DRUG" }, { "name": "Lactated Ringers Solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Thomas Jefferson University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 264, "start_date": "2011-05", "completion_date": "2015-12", "has_results": false, "last_update_posted_date": "2015-03-18", "last_synced_at": "2026-10-24T22:15:44.200Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01428050" } ] }